SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on February 26, 2020, covering events occurring on February 21, 2020, and February 25, 2020. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut, and its common stock trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The report focuses on a capital raising event rather than operational financial performance.
- Capital Raised: The Company closed an underwritten public offering of 2,500,000 shares of common stock.
- Warrants Issued: The Company issued warrants to purchase up to 125,000 shares of common stock at an exercise price of $4.80 per share.
- Underwriter: Laidlaw & Company (UK) Ltd.
Material Changes
The primary material change reported is the closing of the equity offering on February 25, 2020, which resulted in the issuance of new shares and warrants. Additionally, the Company announced its participation in the Cowen & Co. 40th Annual Health Care Conference on February 26, 2020.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future performance, or specific risk factors beyond the standard disclosures inherent in an equity offering. The document incorporates by reference press releases regarding the offering closing and the upcoming conference presentation.
Investor Verification Checklist
- Verify the total net proceeds received from the 2,500,000 share offering by reviewing the attached press release (Exhibit 99.1).
- Confirm the exact terms and expiration date of the 125,000 warrants issued at the $4.80 strike price.
- Review the press release (Exhibit 99.2) for details on the Company's presentation at the Cowen & Co. Health Care Conference.
- Check subsequent filings for the impact of this dilution on the Company's capital structure.